As any organisation involved in pharmaceutical development knows, the damage or complete loss of products that have been in stability storage for several years could represent a significant financial or reputational loss with potential long term repercussions for the company. As stability trials play such a key role in the development of a new drug, what steps can you take to mitigate the risks? What do you need to consider when sourcing a contingency storage service provider? Learn more from our stability team and download our article now.